KLK3 and prostate cancer: In men with a baseline PSA level of less than 4 ng/mL, long-term follow-up indicated that a PSA velocity of 0.2 ng/mL per year had a sensitivity of 52.4% and a specificity of 79.4% in predicting prostate cancer [11].